Joseph Schariter

Title: Joseph Schariter: Innovator in Lipid Nanoparticle Technologies

Introduction

Joseph Schariter is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of lipid nanoparticle technologies, holding a total of 3 patents. His work focuses on innovative methods for delivering therapeutics and prophylactics, particularly through the use of nucleic acid lipid nanoparticles.

Latest Patents

Schariter's latest patents include groundbreaking methods of making lipid nanoparticles. This disclosure features novel methods of producing nucleic acid lipid nanoparticle (LNP) compositions employing a modifying agent after the formation of a precursor nucleic acid lipid nanoparticle. The produced compositions are useful in the delivery of therapeutics and/or prophylactics, such as nucleic acids, to mammalian cells or organs, aiming to regulate polypeptide, protein, or gene expression. Another significant patent involves RNA formulations, which provide improved lipid-based compositions, including lipid nanoparticle compositions, and methods for delivering agents in vivo, including nucleic acids and proteins.

Career Highlights

Joseph Schariter is currently associated with Modernatx, Inc., where he continues to advance the field of lipid nanoparticle technologies. His innovative approaches have positioned him as a key player in the development of new therapeutic delivery systems.

Collaborations

Schariter has collaborated with notable colleagues, including Kimberly Hassett and Mike Smith, contributing to the advancement of their shared research goals.

Conclusion

Joseph Schariter's work in lipid nanoparticle technologies exemplifies the innovative spirit of modern science. His contributions are paving the way for new therapeutic solutions that could significantly impact healthcare.